Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
Orkin C, Molina JM, Cahn P, Lombaard J, Supparatpinyo K, Kumar S, Campbell H, Wan H, Teal V, Jin Xu Z, Asante-Appiah E, Sklar P, Teppler H, Lahoulou R; DRIVE-FORWARD and DRIVE-AHEAD collaborators. Orkin C, et al. Lancet HIV. 2024 Feb;11(2):e75-e85. doi: 10.1016/S2352-3018(23)00258-8. Epub 2023 Dec 20. Lancet HIV. 2024. PMID: 38141637 Clinical Trial.
Letter on the 2023 ACSM Expert Consensus Statement on Exertional Heat Illness.
Casa DJ, Szymanski MR, Jardine JF, Stearns RL, Adams WM, Eason CM, Hosokawa Y, Huggins RA, Lopez RM, McDermott BP, Miller KC, Nolan JK, Pryor RR, Scarneo-Miller SE, Vandermark LW. Casa DJ, et al. Among authors: lopez rm. Curr Sports Med Rep. 2023 Sep 1;22(9):336-337. doi: 10.1249/JSR.0000000000001100. Curr Sports Med Rep. 2023. PMID: 37678353 No abstract available.
161 results